Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Blood|February 7, 1998
Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sourcesB M Léonard, F Hétu, L Busque, et al.
British Journal of Haematology|June 10, 2000
Relapse after bone marrow transplantation: evidence for distinct immunological mechanisms between adult and paediatric populationsM Guimond, L Busque, C Baron, et al.
Bone Marrow Transplantation|June 1, 1996
Sequential analysis of early hematopoietic reconstitution following allogeneic bone marrow transplantation with fluorescence in situ hybridization (FISH)C Lapointe, L Forest, P Lussier, et al.
Nature Genetics|October 3, 1999
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaW J Song, M G Sullivan, R D Legare, et al.
Cancer Genetics and Cytogenetics|December 7, 2000
Translocation (2;8)(p12;q24) associated with a cryptic t(12;21)(p13;q22) TEL/AML1 gene rearrangement in a child with acute lymphoblastic leukemiaM L Loh, Y Samson, E Motte, et al.
Blood|January 7, 1998
CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteinsM Carroll, S Ohno-Jones, S Tamura, et al.
Leukemia|October 19, 2011
EXEL-8232, a small-molecule JAK2 inhibitor, effectively treats thrombocytosis and extramedullary hematopoiesis in a murine model of myeloproliferative neoplasm induced by MPLW515LG Wernig, M G Kharas, A Mullally, et al.
Blood|December 9, 1998
Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemiaM L Loh, L B Silverman, M L Young, et al.
Blood|February 25, 1999
TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitorM H Tomasson, I R Williams, R Hasserjian, et al.
Blood Cancer Journal|November 5, 2020
Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patientsS Thiant, M M Moutuou, P Laflamme, et al.
Pageof 10